Milestone Pharmaceuticals Inc

-

Stock Issuer and Owners

Home | Sign Up | Log In
New Features
Latest Fund Raises
Related People
Fund Service Providers
Startup & Company Raises
List of Funds
Boston Firms
Boston Hedge Funds
Cornell Alumni Firms
CalPERS Portfolio
NYSCRF Portfolio
User Guide
Regulatory AUM vs AUM
LP Portfolios
Related Firms
Build a Portfolio
Comprehensive Search
Keyboard
Milestone Pharmaceuticals Inc
TickerMIST
CIK #0001408443
CUSIP59935V107
SectorLife Sciences - Pharmaceutical Preparations
Address1111 Dr Frederik-Philips Blvd Suite 420, Montreal, QC H4M 2X6
Source [EDGAR]
Reg D Offering (Form D) Filed Raised Terms
Milestone Pharmaceuticals Inc 2018-10-26 80.0 M Exemption: 506(b) · Duration: One year or less · Revenue: Decline to Disclose
CIK Filing 2011 - 2026
[0001408443] 10-K
[0001408443] 10-Q
[0001408443] 3
[0001408443] 4
[0001408443] 8-K
[0001408443] D
[0001408443] SC 13D
[0001408443] SC 13G
Form 13D/13G Filer Form 13D/13G Subject Filed % Owned
Propel Bio Management LLC Milestone Pharmaceuticals Inc [2025-12-23] 0.0
Adage Capital Management LP Milestone Pharmaceuticals Inc [2025-11-13] 0.0
Trails Edge Capital Partners LP Milestone Pharmaceuticals Inc [2025-07-21] 0.0
Alta Fundamental Advisers LLC Milestone Pharmaceuticals Inc [2023-11-09] 5.0
Goldman Sachs Group Inc Milestone Pharmaceuticals Inc [2023-01-19] 8.0
Integrated Core Strategies US LLC Milestone Pharmaceuticals Inc [2022-10-31] 5.3
Venrock Healthcare Capital Partners III LP Milestone Pharmaceuticals Inc [2022-09-20] 6.9
RA Capital Management LP Milestone Pharmaceuticals Inc [2021-02-16] 7.8
OrbiMed Capital LLC Milestone Pharmaceuticals Inc [2021-02-12] 8.36
Ikarian Capital LLC Milestone Pharmaceuticals Inc [2021-01-11] 6.2
Boxer Capital LLC Milestone Pharmaceuticals Inc [2020-08-03] 0.0
Venrock Healthcare Capital Partners II LP Milestone Pharmaceuticals Inc [2020-02-14] 0.0
Price T Rowe Associates Inc /MD/ Milestone Pharmaceuticals Inc [2020-02-14] 5.2
Forbion Capital Fund III Cooperatief UA Milestone Pharmaceuticals Inc [2020-02-11] 5.3
Domain Partners VIII LP Milestone Pharmaceuticals Inc [2020-01-09] 7.6
RTW Investments LP Milestone Pharmaceuticals Inc [2019-05-20] 14.89
Fonds de Solidarite Des Travailleurs Du Quebec Milestone Pharmaceuticals Inc [2019-05-15] 11.5
Novo Holdings A/S Milestone Pharmaceuticals Inc [2019-05-14] 11.31
Form 3/4/5 Filer 2011 - 2026
Wills Robert James
Milestone Pharmaceuticals Inc
Fischer Seth H Z
Tomsicek Michael John
Giles Lisa M
Papa Joseph C
Duty Stuart
Saik Andrew
Oliveto Joseph
Sandoval David I
Nelson Jeffrey Edward
Bharucha David
Muller Lorenz
Hasija Amit
Liebert Debra K
Pasternak Richard C
Wong Roderick
RTW Investments LP
Truex Paul F
Plat Francis
Fonds de Solidarite Des Travailleurs Du Quebec
Edick Paul R
Novo Holdings A/S
Maness Timothy
Douville Philippe
BDC Capital Inc
Kumar Nilesh
Boorsma Marco
Insider Transaction (Form 3/4/5) Date Action Shares Price Value ($)
Nelson Jeffrey Edward
Employee Stock Option (right to buy) · derivative
2026-02-02 Grant 204,000 $0.00
Nelson Jeffrey Edward
Restricted Stock Unit · derivative
2026-02-02 Grant 136,000 $0.00
Muller Lorenz
Restricted Stock Unit · derivative
2026-02-02 Grant 136,000 $0.00
Muller Lorenz
Employee Stock Option (right to buy) · derivative
2026-02-02 Grant 204,000 $0.00
Oliveto Joseph
Restricted Stock Unit · derivative
2026-02-02 Grant 453,000 $0.00
Employee Stock Option (right to buy) · derivative
2026-02-02 Grant 204,000 $0.00
Employee Stock Option (right to buy) · derivative
2026-02-02 Grant 204,000 $0.00
Employee Stock Option (right to buy) · derivative
2026-02-02 Grant 679,000 $0.00
Employee Stock Option (right to buy) · derivative
2026-02-02 Grant 204,000 $0.00
Employee Stock Option (right to buy) · derivative
2026-02-02 Grant 204,000 $0.00
Bharucha David
Employee Stock Option (right to buy) · derivative
2026-02-02 Grant 204,000 $0.00
Bharucha David
Restricted Stock Unit · derivative
2026-02-02 Grant 136,000 $0.00
Oliveto Joseph
Employee Stock Option (right to buy) · derivative
2026-02-02 Grant 679,000 $0.00
Hasija Amit
Employee Stock Option (right to buy) · derivative
2026-02-02 Grant 204,000 $0.00
Hasija Amit
Restricted Stock Unit · derivative
2026-02-02 Grant 136,000 $0.00
Muller Lorenz
Restricted Stock Units · derivative
2026-01-26 Option exercise 20,100 $0.00
Nelson Jeffrey Edward
Common Shares
2026-01-26 Option exercise 20,100
Nelson Jeffrey Edward
Common Shares
2026-01-26 Sell 12,245 $1.93 23,633
Muller Lorenz
Common Shares
2026-01-26 Option exercise 20,100
Muller Lorenz
Common Shares
2026-01-26 Sell 11,180 $1.93 21,577
showing 20 of 200 most recent transactions
13F Ownership Over TimeHoldersShares Held
2026-03-31 86 30,766,604
2025-12-31 79 27,518,541
2025-09-30 61 34,380,287
2025-06-30 46 12,054,106
2025-03-31 46 12,235,170
2024-12-31 48 24,652,680
2024-09-30 44 28,677,899
2024-06-30 42 31,961,531
2024-03-31 44 32,988,407
2023-12-31 41 18,745,599
2023-09-30 39 19,558,424
2023-06-30 49 20,693,565
Form 13F Holdings
Firm Period DFND Voting Shares
Simplify Asset Management Inc [2026-06-30] SOLE 3,349,379 3,349,379
Valeo Financial Advisors LLC [2026-06-30] SOLE 130,699 130,699
Bay Rivers Group [2026-06-30] SOLE 0 46,633
Secure Asset Management LLC [2026-06-30] SOLE 0 10,000
Integral Investment Advisors Inc [2026-06-30] SOLE 0 10,000
Prev | Page 1 | Next
Terms | Privacy | Providers | Companies | Guide
tony@aum13f.com